Metagenomics Market
At an estimated value of over USD 275.3 million in 2019, the Global Metagenomics Market is predicted to thrive at a CAGR of 14.5% and valued at over USD 1.22 billion over the forecast year 2020-2030.
Metagenomics encompasses various studies that use bioinformatic tools as well as sequencing technologies to attain valuable understanding on the varieties in the microbial community and microbes’ interaction in a community. These studies are making advancements across environmental & clinical microbiology, despite considerable barriers such as difficulty to enable a microbial culture, which is a method of multiplying microbial organisms. The technologies in metagenomics have allowed enhanced understanding of the microbial ecosystem along with the role of microbiology in the geochemical cycles. This has led to the understanding of the enormous microbial diversity for researchers, fueling the global market growth.
Access Full Description of this report at:-
https://www.nextmsc.com/report/metagenomics-market
Top Companies: Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., Enterome SA, Illumina, Inc., Pacific Biosciences of California, Inc., Oxford Nanopore Technologies Ltd., PerkinElmer, Inc., Swift Biosciences, Inc., Qiagen N.V., Thermo Fisher Scientific, Inc and others.
The global metagenomics market share is segmented on the basis of product, technology, application, and geography. On the basis of product type, the market is categorized into instrument & software and consumable. On the basis of technology, the market is segmented into bioinformatics and sequencing. On the basis of application, the market is segmented into infectious disease diagnosis, environmental remediation, biotechnology, gut microbe characterization, biofuel, and agriculture. Geographic fragmentation and analysis of each segment includes regions comprising North America, Europe, Asia Pacific and RoW.
Request sample copy of this report at:-
https://www.nextmsc.com/metagenomics-market/request-sample
In terms of geography, North America held major share of the market in 2019. This is due to the growing adoption of DNA sequencing across metagenomic applications in the region. In addition, surge in the implementation of novel sequencing technologies across the region has significantly contributed to its dominance. However, Asia pacific is expected to grow rapidly with increasing market size due to the significant patient pool as well as the rapidly evolving healthcare infrastructure in countries such as China, India, and Japan.
About Next Move Strategy Consulting:
Next Move Strategy Consulting is an independent and trusted third-platform market intelligence provider, committed to deliver high quality, market research reports that help multinational companies to triumph over their competitions and increase industry footprint by capturing greater market share. Our research model is a unique collaboration of primary research, secondary research, data mining and data analytics.
We have been servicing over 1000 customers globally that includes 90% of the Fortune 500 companies over a decade. Our analysts are constantly tracking various high growth markets and identifying hidden opportunities in each sector or the industry. We provide one of the industry’s best quality syndicate as well as custom research reports across 10 different industry verticals. We are committed to deliver high quality research solutions in accordance to your business needs. Our industry standard delivery solution that ranges from the pre consultation to after-sales services, provide an excellent client experience and ensure right strategic decision making for businesses.
For more insights, please visit, https://www.nextmsc.com
